TLR3 and demyelinating disease: Therefore, it would be important to investigate the effects of different levels of type I IFNs that are activated via TLR3 in resistant and susceptible mice to determine its impact on the development of TMEV-induced demyelinating disease, which bears both viral and autoimmunity components.